Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Side-Lying pelvic exam could ease patient anxiety

NCT ID NCT05880290

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a gynecological exam done while lying on the side (lateral decubitus) works well enough to be a regular option. Over 500 women who needed a pelvic exam tried this position. The goal was to see if it is effective and more comfortable, which could help more women get regular check-ups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

547 people

The number who actually took part.

Started

Jul 2023

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Woman of legal age, 18 years or older. * Who already had a gynaecological examination in the conventional position. * Requiring a gynaecological consultation in primary care with speculum for screening, diagnosis or prevention. * Woman of childbearing age with a negative urine pregnancy test or postmenopausal woman (no period in the last 12 months). * Patient who has read and understood the information letter and signed the consent form. * Affiliated to the social security. Exclusion Criteria: * Pregnant woman * Who already participated to this protocol * Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection / sub-guardianship or curatorship. * Major cognitive impairment that prevents the subject from fully understanding the requirements for participation in the study or from giving informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Medical care are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • BIHOREL

    Bihorel, 76420, France

  • BOOS 1

    Rouen, 76100, France

  • BOOS 2

    Boos, 76520, France

  • Bois-Guillaume

    Bois-Guillaume, 76230, France

  • Le Havre 1

    Le Havre, France

  • Le Havre 2

    Le Havre, 76620, France

  • Le Havre 3

    Le Havre, 76600, France

  • Lillebonne

    Lillebonne, 76190, France

  • Louviers 1

    Louviers, 27400, France

  • Louviers 2

    Louviers, 27400, France

  • Louviers 3

    Louviers, 27400, France

  • MALAUNAY

    Malaunay, 76770, France

  • Montivillers 2

    Montivilliers, 76290, France

  • Montivilliers 1

    Montivilliers, 76290, France

  • Octeville Sur Mer

    Octeville, 76930, France

  • Offranville

    Offranville, 76550, France

  • ROUEN 1

    Rouen, 76100, France

  • ROUEN 2

    Rouen, 76100, France

  • ROUEN 3

    Rouen, 76100, France

  • ROUEN 4

    Rouen, 76000, France

  • YVETOT

    Yvetot, 76190, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.